Shire Rejecting AbbVie’s Bid Puts It in Play: Real M&A – Businessweek

Businessweek
AbbVie Inc. (ABBV:US) yesterday revealed a $46.5 billion takeover bid for Shire in the first public acquisition approach for the specialty drugmaker after years of takeover speculation. While Shire rejected the offer, AbbVie is already considering raising it, two …
Two tales of upstart pharmaFinancial Times
Drug Maker Shire Rejects Offer From AbbVie Worth About $46 BillionNew York Times
FTSEurofirst ends near 6 1/2-yr high, Shire surges on takeover offerReuters
Barron’s (blog)MarketWatchEconomic Times
all 329 news articles

…read more

Source: Business News From Google News

Leave a Comment